The complainant made claims related to Novo’s alleged promotion of Saxenda, its older GLP-1 weight-loss drug, and sponsorship of pharmacy chains.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best strong buy growth stocks to buy now. On August 28, Teva ...

Weight loss injections can help with weight loss. They can help alter the body's appetite and metabolism, reducing hunger and overall calorie intake. Read more.

Discover the weight loss benefits of semaglutide and liraglutide for obese patients. Cleveland Clinic study examines Wegovy, Ozempic, Saxenda and Victoza.

In December 2024, Teva also secured FDA approval for the other liraglutide brand Victoza, indicated for type 2 diabetes.

The demand for weight loss operations dropped sharply last year as the number of people opting for anti-obesity drugs such as Wegovy and Saxenda more than doubled, a study published Friday found.

Generic Saxenda® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the ...

Teva is releasing a generic version of Novo Nordisk’s Saxenda, a liraglutide injection. Liraglutide injection is indicated for adults with obesity or overweight who also have weight related medical ...

The FDA has approved several medications that help with weight loss and treat obesity. Some are made from semaglutide, tirzepatide, or orlistat.

Novo Nordisk faces scrutiny over UK pharmacy sponsorships tied to weight-loss drugs, with critics citing conflicts of interest and regulatory breaches.

Medicare drug plans don’t cover Saxenda because Medicare doesn’t cover GLP-1 agonists when prescribed for weight loss.

Best for Comprehensive Medication Options: Hims | Jump to Review Hims stands out for its wide range of prescription weight loss treatments, including both oral medications and GLP-1 injections.